Literature DB >> 23146148

Electrophysiological and motor function scale association in a pre-symptomatic infant with spinal muscular atrophy type I.

Richard S Finkel1.   

Abstract

A term infant, at familial risk for spinal muscular atrophy (SMA), had the diagnosis genetically confirmed on day 3 of life. Clinical evaluation, the CHOP INTEND motor scale and the CMAP amplitude were obtained on days 5 (pre-symptomatic), 20 (mildly weak), 34 (moderately weak) and 63 (severely weak). Palliative care was provided and he expired of an acute pulmonary infection on day 81. The CMAP amplitude and INTEND scores were initially in the normal range, then followed a corresponding decline to a nadir at day 34 and remained so at the 4th assessment. A log-transformed plot of CMAP amplitude from days 5-34 was linear. These data suggest that early motor neuron loss in SMA type I may be logarithmic and demonstrates that the INTEND motor scale closely follows the CMAP electrophysiological biomarker. This single case report supports the consideration that early intervention with a potential therapy is necessary, before the pool of functional motor neurons has plummeted. Further study of these parameters in pre-symptomatic infants with SMA type I will help guide the design of future intervention studies.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23146148     DOI: 10.1016/j.nmd.2012.09.006

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  17 in total

Review 1.  Spinal muscular atrophy: diagnosis and management in a new therapeutic era.

Authors:  W David Arnold; Darine Kassar; John T Kissel
Journal:  Muscle Nerve       Date:  2014-12-16       Impact factor: 3.217

Review 2.  Time Is Motor Neuron: Therapeutic Window and Its Correlation with Pathogenetic Mechanisms in Spinal Muscular Atrophy.

Authors:  Alessandra Govoni; Delia Gagliardi; Giacomo P Comi; Stefania Corti
Journal:  Mol Neurobiol       Date:  2018-01-02       Impact factor: 5.590

Review 3.  Antisense oligonucleotides for the treatment of spinal muscular atrophy.

Authors:  Paul N Porensky; Arthur H M Burghes
Journal:  Hum Gene Ther       Date:  2013-05       Impact factor: 5.695

4.  Adaptations of motoneuron properties to chronic compensatory muscle overload.

Authors:  P Krutki; A Hałuszka; W Mrówczyński; P F Gardiner; J Celichowski
Journal:  J Neurophysiol       Date:  2015-02-18       Impact factor: 2.714

5.  A large animal model of spinal muscular atrophy and correction of phenotype.

Authors:  Sandra I Duque; W David Arnold; Philipp Odermatt; Xiaohui Li; Paul N Porensky; Leah Schmelzer; Kathrin Meyer; Stephen J Kolb; Daniel Schümperli; Brian K Kaspar; Arthur H M Burghes
Journal:  Ann Neurol       Date:  2015-02-09       Impact factor: 10.422

Review 6.  Spinal muscular atrophy - insights and challenges in the treatment era.

Authors:  Eugenio Mercuri; Maria Carmela Pera; Mariacristina Scoto; Richard Finkel; Francesco Muntoni
Journal:  Nat Rev Neurol       Date:  2020-10-14       Impact factor: 42.937

7.  Biodistribution of onasemnogene abeparvovec DNA, mRNA and SMN protein in human tissue.

Authors:  Gretchen Thomsen; Arthur H M Burghes; Caroline Hsieh; Janet Do; Binh T T Chu; Stephanie Perry; Basam Barkho; Petra Kaufmann; Douglas M Sproule; Douglas E Feltner; Wendy K Chung; Vicki L McGovern; Robert F Hevner; Miriam Conces; Christopher R Pierson; Mariacristina Scoto; Francesco Muntoni; Jerry R Mendell; Kevin D Foust
Journal:  Nat Med       Date:  2021-10-04       Impact factor: 53.440

Review 8.  SMN regulation in SMA and in response to stress: new paradigms and therapeutic possibilities.

Authors:  Catherine E Dominguez; David Cunningham; Dawn S Chandler
Journal:  Hum Genet       Date:  2017-08-29       Impact factor: 4.132

9.  The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy.

Authors:  W Arnold; Vicki L McGovern; Benjamin Sanchez; Jia Li; Kaitlyn M Corlett; Stephen J Kolb; Seward B Rutkove; Arthur H Burghes
Journal:  Neurobiol Dis       Date:  2015-12-28       Impact factor: 5.996

Review 10.  Spinal muscular atrophy: development and implementation of potential treatments.

Authors:  W David Arnold; Arthur H M Burghes
Journal:  Ann Neurol       Date:  2013-09       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.